Connection

Marco Massari to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Marco Massari has written about Clinical Trials, Phase II as Topic.
Marco Massari
Connection Strength
0.042
Clinical Trials, Phase II as Topic
  1. TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol. Contemp Clin Trials. 2020 11; 98:106165.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.